Krka Posts Excellent Q1 Results
Novo Mesto, 22 April - Drug maker Krka posted first quarter sales of SIT 28bn (EUR 117.5m), up 36 percent year-on-year and 11 percent above the target. Q1 net profits meanwhile doubled over last year, to SIT 4.2bn (EUR 17.6m), the company said in Thursday's press release.
The rest of this news item is available to subscribers.
The news item consists of 681 characters (without spaces) or 130 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.